Pfizer Inc

NYSE: PFE
$26.02
-$0.62 (-2.3%)
Real Time Data Delayed 15 Min.

PFE Articles

These four solid companies have released good earnings and pay consistent and healthy dividends. All make more sense going forward for investors getting a little nervous about what the rest of 2019...
The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell, ServiceNow and Tiffany.
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
Pfizer released better-than-expected fourth-quarter financial results and guidance before the markets opened on Tuesday.
Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest year-over-year growth.
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this week, including Apple, Exxon and Microsoft.
24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price. We have also added in some additional color on these companies as well.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer, Tesla, Teva Pharmaceutical and...
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average in 2019.
Investors love their dividends. So 24/7 Wall St. has tracked the Dogs of the Dow strategy for years now.
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
These six safer stocks all carry Merrill Lynch’s best volatility risk rating and pay dependable dividends. They offer reasonable entry points too.
GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining...
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.